AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scarmeas, N.
Right arrow Articles by Stern, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scarmeas, N.
Right arrow Articles by Stern, Y.
Am J Geriatr Psychiatry 12:596-605, December 2004
© 2004 American Association for Geriatric Psychiatry


Regular Article

Altered PET Functional Brain Responses in Cognitively Intact Elderly Persons at Risk for Alzheimer Disease (Carriers of the {epsilon}4 Allele)

Nikolaos Scarmeas, M.D., Christian Habeck, Ph.D., Karen E. Anderson, M.D., John Hilton, Ph.D., Davangere P. Devanand, M.D., Gregory H. Pelton, M.D., Matthias H. Tabert, Ph.D., Joseph Flynn, Aileen Park, Alejandra Ciappa, M.D., Benjamin Tycko, M.D., Ph.D., and Yaakov Stern, Ph.D.

Received August 20, 2003; revised January 13, April 16, 2004; accepted April 21, 2004. From the Cognitive Neuroscience Division of the Taub Institute for Research in Alzheimer's Disease and the Aging Brain (JF,AP,NS,CH,JH,AC,YS) and the Departments of Neurology (NS,YS), Psychiatry (GHP,MHT,DPD,YS) and Pathology (BT), College of Physicians and Surgeons of Columbia University, New York; and the Department of Psychiatry, University of Maryland, Baltimore, MD (KEA). Send correspondence to Nikolaos Scarmeas, M.D., Columbia University Medical Center; 622 West 168th St., PH 19th floor; New York, NY 10032. e-mail Note: ns257{at}columbia.edu
©2004 American Association for Geriatric Psychiatry

Objective: Few previous studies have investigated the association between APOE genotype and brain activation during performance of cognitive tasks in healthy middle-aged and elderly subjects, and the results have been mixed. The authors investigated APOE-mediated differential brain activation in a group of healthy elderly subjects. Methods: Using H215O positron emission tomography (PET), they imaged 32 healthy subjects (26 non-{epsilon}4 carriers and 6 {epsilon}4 carriers) performing a serial shape-recognition memory task under two conditions: Simple Demand (SD), in which one shape was presented in each study trial, and Titrated Demand (TD), in which study list length was adjusted so that each subject recognized words at approximately 75% accuracy. Multiple-regression analyses were performed, with the "activation" difference (TD–SD PET counts) as the dependent variable and the APOE genotype (presence versus absence of the {epsilon}4 allele) as the independent variable. Results: Compared with non-carriers, {epsilon}4 carriers exhibited significantly decreased TD–SD activation differences in the left superior temporal, right superior frontal, left postcental, left precuneus, and posterior cingulate gyrus because {epsilon}4 carriers (versus non-carriers) showed increased activation during the SD and decreased activation during the TD condition. Conclusion: Patterns of brain activation during a nonverbal memory task differed as a function of APOE genotype and, therefore, of genetic risk for Alzheimer disease (AD). Differences in activation were not a reflection of task difficulty, but indicate memory-related altered cognitive processing. Brain regions with decreased activation in the {epsilon}4 subjects may result from subclinical incipient AD pathology and/or APOE-related neurophysiologic heterogeneity.

Key Words: PET Studies • Neuroimaging • Genetic Studies • Cognition




This article has been cited by other articles:


Home page
AJGPHome page
N. Pomara, K. Belzer, R. Hernando, C. De La Pena, and J. J. Sidtis
Increased Mental Slowing Associated With the APOE {varepsilon}4 Allele After Trihexyphenidyl Oral Anticholinergic Challenge in Healthy Elderly
Am J Geriatr Psychiatry, February 1, 2008; 16(2): 116 - 124.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Scarmeas, J. A. Luchsinger, R. Mayeux, and Y. Stern
Mediterranean diet and Alzheimer disease mortality
Neurology, September 11, 2007; 69(11): 1084 - 1093.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Scarmeas, Y. Stern, M. W. Bondi, and S. D. Han
fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease
Neurology, November 8, 2005; 65(9): 1514 - 1515.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N Scarmeas, C G Habeck, J Hilton, K E Anderson, J Flynn, A Park, and Y Stern
APOE related alterations in cerebral activation even at college age
J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1440 - 1444.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2004 American Association for Geriatric Psychiatry